Cartesian Therapeutics Inc. (NASDAQ: RNAC)
$17.96
+0.0400 ( +0.22% ) 158.5K
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Market Data
Open
$17.96
Previous close
$17.92
Volume
158.5K
Market cap
$383.76M
Day range
$17.88 - $18.79
52 week range
$11.67 - $41.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
8-k | 8K-related | 14 | Mar 14, 2024 |
10-k | Annual reports | 140 | Mar 07, 2024 |
8-k | 8K-related | 16 | Mar 07, 2024 |
8-k | 8K-related | 16 | Mar 05, 2024 |
def | Proxies and info statements | 9 | Feb 14, 2024 |